Logo image of CLVR

CLEVER LEAVES HOLDINGS INC (CLVR) Stock Price, Forecast & Analysis

USA - NASDAQ:CLVR - CA1867602031 - Common Stock

3 USD
+0.89 (+42.18%)
Last: 5/16/2024, 8:00:00 PM
3.05 USD
+0.05 (+1.67%)
After Hours: 5/16/2024, 8:00:00 PM

CLVR Key Statistics, Chart & Performance

Key Statistics
Market Cap5.25M
Revenue(TTM)17.42M
Net Income(TTM)-17905000
Shares1.75M
Float1.54M
52 Week High8.4
52 Week Low1.38
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-11.4
PEN/A
Fwd PEN/A
Earnings (Next)08-12 2024-08-12/amc
IPO2020-12-18
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


CLVR short term performance overview.The bars show the price performance of CLVR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40 60

CLVR long term performance overview.The bars show the price performance of CLVR in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CLVR is 3 USD. In the past month the price decreased by -26.74%. In the past year, price decreased by -60.1%.

CLEVER LEAVES HOLDINGS INC / CLVR Daily stock chart

CLVR Latest News, Press Relases and Analysis

CLVR Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 39.24 816.66B
JNJ JOHNSON & JOHNSON 18.2 454.86B
AZN ASTRAZENECA PLC-SPONS ADR 18.56 255.48B
NVS NOVARTIS AG-SPONSORED ADR 13.83 239.64B
NVO NOVO-NORDISK A/S-SPONS ADR 12.81 219.77B
MRK MERCK & CO. INC. 9.87 214.76B
PFE PFIZER INC 7.27 140.15B
SNY SANOFI-ADR 11.52 123.27B
GSK GSK PLC-SPON ADR 7.73 94.25B
BMY BRISTOL-MYERS SQUIBB CO 7.02 93.77B
ZTS ZOETIS INC 23.17 63.86B
TAK TAKEDA PHARMACEUTIC-SP ADR 48 42.45B

About CLVR

Company Profile

CLVR logo image Clever Leaves Holdings Inc is a CO-based company operating in Pharmaceuticals industry. The company employs 400 full-time employees The company went IPO on 2020-12-18. Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The firm's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. The company offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.

Company Info

CLEVER LEAVES HOLDINGS INC

Bodega 19-B Parque Industrial Tibitoc Ph, Tocancipa - Cundinamarca

Boca Raton FLORIDA 10017 CO

CEO: Kyle Detwiler

Employees: 400

CLVR Company Website

Phone: 16468804382.0

CLEVER LEAVES HOLDINGS INC / CLVR FAQ

Can you describe the business of CLEVER LEAVES HOLDINGS INC?

Clever Leaves Holdings Inc is a CO-based company operating in Pharmaceuticals industry. The company employs 400 full-time employees The company went IPO on 2020-12-18. Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The firm's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. The company offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.


What is the stock price of CLEVER LEAVES HOLDINGS INC today?

The current stock price of CLVR is 3 USD. The price increased by 42.18% in the last trading session.


Does CLVR stock pay dividends?

CLVR does not pay a dividend.


What is the ChartMill rating of CLEVER LEAVES HOLDINGS INC stock?

CLVR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


On which exchange is CLVR stock listed?

CLVR stock is listed on the Nasdaq exchange.


What is the analyst forecast for CLVR stock?

6 analysts have analysed CLVR and the average price target is 24.48 USD. This implies a price increase of 716% is expected in the next year compared to the current price of 3.


What is the Price/Earnings (PE) ratio of CLEVER LEAVES HOLDINGS INC (CLVR)?

CLEVER LEAVES HOLDINGS INC (CLVR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-11.4).


CLVR Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CLVR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CLVR. CLVR may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CLVR Financial Highlights

Over the last trailing twelve months CLVR reported a non-GAAP Earnings per Share(EPS) of -11.4. The EPS increased by 78.15% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -57.31%
ROE -73.94%
Debt/Equity 0.03
Chartmill High Growth Momentum
EPS Q2Q%85.01%
Sales Q2Q%0.61%
EPS 1Y (TTM)78.15%
Revenue 1Y (TTM)4.8%

CLVR Forecast & Estimates

6 analysts have analysed CLVR and the average price target is 24.48 USD. This implies a price increase of 716% is expected in the next year compared to the current price of 3.

For the next year, analysts expect an EPS growth of 29.03% and a revenue growth 50% for CLVR


Analysts
Analysts43.33
Price Target24.48 (716%)
EPS Next Y29.03%
Revenue Next Year50%

CLVR Ownership

Ownership
Inst Owners2.55%
Ins Owners342.65%
Short Float %0.53%
Short Ratio0.13